1. Home
  2. MARPS vs SSKN Comparison

MARPS vs SSKN Comparison

Compare MARPS & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marine Petroleum Trust Units of Beneficial Interest

MARPS

Marine Petroleum Trust Units of Beneficial Interest

HOLD

Current Price

$4.09

Market Cap

8.5M

Sector

Energy

ML Signal

HOLD

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.41

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MARPS
SSKN
Founded
1956
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
8.9M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
MARPS
SSKN
Price
$4.09
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
6.5K
80.8K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
8.56%
N/A
EPS Growth
N/A
N/A
EPS
0.31
N/A
Revenue
$965,040.00
$30,980,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.74
P/E Ratio
$13.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$1.24
52 Week High
$7.90
$3.86

Technical Indicators

Market Signals
Indicator
MARPS
SSKN
Relative Strength Index (RSI) 37.79 44.94
Support Level $4.19 $1.37
Resistance Level $4.43 $1.52
Average True Range (ATR) 0.14 0.09
MACD -0.00 0.02
Stochastic Oscillator 0.00 43.48

Price Performance

Historical Comparison
MARPS
SSKN

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: